Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Neuropharmacology. Author manuscript; available in PMC 2010 October 24.
Published in final edited form as:
Neuropharmacology. 2010 September; 59(3): 218.
doi:  10.1016/j.neuropharm.2010.05.006
PMCID: PMC2962934

Corrigendum to “Central vasopressin V1a receptors modulate neural processing in mothers facing intruder threat to pups” [Neuropharmacology 58 (2010) 107-116]

The authors of the above paper regret that the incorrect name was given for the V1a receptor antagonist drug that was administered to rats before MRI experiments. The correct name for the drug is [β-Mercapto-β,β-cyclopentamethylenepropionyl1, O-me-Tyr2,Arg8]-Vasopressin (commercially available through Sigma-Aldrich, St. Louis, MO; Product #V2255) and was not [deamino-Pen(1), O-Me-Tyr, Arg(8)]-Vasopressin. The incorrect name was for a nonselective V1 receptor antagonist that was not used in the study.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errorsmaybe discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.